© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity

More articles

More articles

More articles

  • Samsung BioLogics Co has started gauging investor interest for an up to W2.25tr ($2bn) IPO on the main Kospi board in South Korea, with bookbuilding set to begin in mid-October.
  • One of the most regular names in Europe’s equity block trade market, Abertis Infraestructuras, was the subject of another deal on Monday night, with regular bookrunners UBS, Bank of America Merrill Lynch and JP Morgan at the helm.
  • OfficeFirst Immobilien, which owns a German office portfolio spun off by IVG Immobilien, has opened the books for its Frankfurt IPO, with a price range that could value it at up to €1.82bn.
  • ConvaTec, the UK medical supplies company, has announced plans for an IPO of at least $1.8bn (£1.4bn) on the London Stock Exchange this autumn in an intention-to-float document issued on Monday morning.
  • China Merchants Securities Co raised HK$10.7bn ($1.4bn) in its Hong Kong IPO, pricing the shares below the middle of expectations as bankers on the deal voiced differing opinions on its execution.
  • The Securities & Exchange Commission of Pakistan (SECP) said the country’s stock exchange will complete a 40% sale this year, but declined to confirm if the Shanghai bourse was eyeing the stake.
shared comment list